A relationship between tumor thickness and histopathological growth patterns in basal cell carcinoma (BCC) investigated.
Relapse-free survival outcomes were similar between real-world and clinical trial patients.
Vismodegib treatment in local advanced and metastatic basal cell carcinoma is assessed.
As part of its ongoing implementation of new authorities for certain over-the-counter drugs, the FDA has taken actions aimed at improving the quality, safety, and efficacy of sunscreens.
The largest AK whole-exsome sequencing study to date is reported on.
For patients with previously untreated metastatic uveal melanoma, treatment with tebentafusp results in longer overall survival than control therapy.
Adjuvant pembrolizumab prolongs relapse-free survival, when compared with placebo, in patients with resected, stage II melanoma.
Median OS was not reached for the T-VEC plus pembrolizumab arm and 49.2 months for the placebo plus pembrolizumab arm.
A retrospective study evaluated the effect of 5% imiquimod prior to Mohs surgery in patients with basal cell carcinoma.
The frequency and severity of skin reactions in patients with actinic keratosis is evaluated.